Keyphrases
Prostate Cancer
100%
Androgen Receptor
100%
Cancer Growth
100%
Selective Androgen Receptor Modulator
100%
Androgens
28%
Androgen Signaling
28%
Clinical Response
14%
Clinical Improvement
14%
Homeostasis
14%
Small Molecules
14%
Metabolism
14%
Receptor Binding
14%
Receptor Agonist
14%
Activity Level
14%
Master Regulator
14%
Clinical Investigation
14%
Therapeutic Agents
14%
Antitumor Effect
14%
Testosterone
14%
Oncology
14%
Advanced Prostate Cancer
14%
Orally Administered
14%
Low Activity
14%
Muscle Wasting
14%
Quality of Life Improvement
14%
Receptor Complex
14%
Drug-like
14%
Dihydrotestosterone
14%
Steroidal
14%
Supraphysiological
14%
Castration-resistant Prostate Cancer
14%
Frontline Therapy
14%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
14%
Prostate Development
14%
Non-steroidal
14%
Activating Ligands
14%
Cistrome
14%
HOXB13
14%
Prostate Cancer Model
14%
Castration-sensitive
14%
Muscle Cachexia
14%
MYC Oncoprotein
14%
Coregulatory Proteins
14%
Bioavailable Concentration
14%
GRHL2
14%
Medicine and Dentistry
Prostate Cancer
100%
Cancer Growth
100%
Androgen Receptor
100%
Selective Androgen Receptor Modulator
100%
Androgen
22%
In Vitro
11%
Cachexia
11%
Homeostasis
11%
Clinical Study
11%
Therapeutic Agent
11%
Quality of Life
11%
Oncology
11%
Montelukast
11%
Muscle Atrophy
11%
Oncoprotein
11%
Androstanolone
11%
Receptor Binding
11%
Cancer Model
11%
Castration Resistant Prostate Cancer
11%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Cancer Growth
100%
Androgen Receptor
100%
Selective Androgen Receptor Modulator
100%
Androgen
22%
Clinical Study
11%
Receptor Agonist
11%
Cancer Model
11%
Oncoprotein
11%
Montelukast
11%
Muscle Atrophy
11%
Androstanolone
11%
Castration Resistant Prostate Cancer
11%
Cachexia
11%